CDXS News and Press, Codexis Inc. From 11/02/23

2023-11-02 21:32:19 ET Codexis, Inc. (CDXS) Q3 2023 Earnings Conference Call November 02, 2023, 04:30 PM ET Company Participants Carrie McKim - Director of IR Stephen Dilly - President and CEO Kevin Norrett - Chief Operating Officer Sri Ryali - CFO Conf...

2023-11-02 17:10:02 ET More on Codexis Checking Out Codexis Codexis announces a San Carlos facility lease that could potentially save $30M Seeking Alpha’s Quant Rating on Codexis For further details see: Codexis reports mixed Q3 earnings; reaffirms...

Company Remains on Track to Demonstrate Gram-Scale Synthesis with ECO Synthesis™ Platform for RNAi Therapeutics Production by End of Year Strong Financial Position Enables Projected Runway to Expected Positive Cash Flow Around End of 2026 Company to Host Virtual ECO Synth...

Acushnet Holdings Corp. (GOLF) is expected to report $0.54 for Q3 2023 Paramount Global (PARA) is expected to report $0.09 for Q3 2023 Curis Inc. (CRIS) is expected to report $-2.32 for Q3 2023 Quanta Services Inc. (PWR) is expected to report $1.99 for Q3 2023 GRI Bio Inc. (GRI) i...

Codexis Inc. (CDXS) is expected to report $-0.32 for Q3 2023

2023-11-01 13:22:14 ET More on Codexis Checking Out Codexis Codexis announces a San Carlos facility lease that could potentially save $30M Seeking Alpha’s Quant Rating on Codexis Historical earnings data for Codexis Financial information for Co...

REDWOOD CITY, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced a presentation highlighting the role of an enzymatic approach to support RNA-based therapeutics manufacturing at the TIDES Europe annual meeting taking place...

2023-10-21 03:29:32 ET Summary Cathie Wood and ARK Investment Management have abandoned their "soft landing" theory and are actively preparing for other scenarios. ARK now expects an "economic landing stronger than soft", while facing more than a billion in net fund outflows since...

REDWOOD CITY, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced that it will report its financial results for the third quarter of 2023 on Thursday, November 2, 2023, following the close of market. Codexis management will...

2023-10-05 14:11:41 ET Summary Codexis, Inc. is undergoing a significant restructuring to reduce costs, refocus its developmental efforts and streamline its organization. The company's ECO platform to provide enzymes for RNA therapeutics shows some potential, but the company's cas...